Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine

Current cancer immunotherapies predominantly rely on CD8(+) T cells to fight against tumors. However accumulative evidence showed that proinflammatory CD4(+) helper T cells are critical determinants of effective antitumor immunity. The utilization of universal tumor-reactive helper peptides from tel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Adotévi, Olivier, Dosset, Magalie, Galaine, Jeanne, Beziaud, Laurent, Godet, Yann, Borg, Christophe
Format: Artigo
Sprache:Inglês
Veröffentlicht: Landes Bioscience 2013
Schlagworte:
Commentary
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3899142/
https://ncbi.nlm.nih.gov/pubmed/23357860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.23587
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge